Immunotherapy for Cancer - NCI
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. Learn about the types of immunotherapy and what you can expect during treatment.

Side Effects of Immunotherapy - NCI - National Cancer Institute
Immunotherapy side effects happen when the immune system that has been prompted to act against the cancer also acts against healthy cells and tissues in the body. Learn about the types of side effects that immunotherapy might cause and where to go for more information.

Immune Checkpoint Inhibitors - NCI - National Cancer Institute
Immune checkpoint inhibitors are a type of immunotherapy that block immune checkpoint proteins from binding with partner proteins. Learn about the cancers treated with checkpoint inhibitors and the side effects they may cause.

Definition of immunotherapy - NCI Dictionary of Cancer Terms
Immunotherapy uses the body’s immune system to fight cancer. This animation explains three types of immunotherapy used to treat cancer: nonspecific immune stimulation, T-cell transfer therapy, and immune checkpoint inhibitors.

Imfinzi, Keytruda Approved for Some Endometrial Cancers
FDA has approved three new immunotherapy options, including pembrolizumab (Keytruda) and durvalumab (Imfinzi), with chemo for advanced endometrial cancer.

CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Just a decade or so ago, immunotherapy was considered an exciting new way to treat some people with very advanced forms of a few types of cancer. Today, it’s a cornerstone of cancer treatment. A form of immunotherapy that has generated tremendous excitement are CAR T-cell therapies.

Immunotherapy Combo Approved for dMMR Colorectal Cancer
The Food and Drug Administration (FDA) has approved the combination of two immunotherapy drugs for the initial treatment of some people with advanced colorectal cancer.

Pembrolizumab improves outcomes in high-risk bladder cancer
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

Inmunoterapia para el cáncer - National Cancer Institute
La inmunoterapia es un tratamiento que ayuda al sistema inmunitario a combatir el cáncer. Obtenga información sobre los tipos diferentes de inmunoterapia y lo que puede esperar durante este tratamiento.

Nivolumab - NCI - National Cancer Institute
Nivolumab works by binding to and blocking the protein PD-1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system. This allows the immune system to attack the cancer cells. Nivolumab is a type of immunotherapy drug called an immune checkpoint inhibitor.